VIE

Viela Bio Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

VIE price

Viela Bio

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VIE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals VIE

Valuation

P/E

Sector -3.32

Industry -3.32

P/BV

Sector 1.89

Industry 1.89

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

Sector -219.27

Industry -219.27

EV/EBIT

Sector -48.32

Industry -48.32

P/EBITDA

0.00

Sector -22.46

Industry -22.46

P/EBIT

0.00

Sector -29.91

Industry -29.91

P/Total Assets

0.00

Sector 1.12

Industry 1.12

P/Net Current Assets

Sector -9.48

Industry -9.48

P/Working Capital

Sector -148.59

Industry -148.59

EPS

-2.39

Sector -1.78

Industry -1.78

BVPS

6.85

Sector 1.98

Industry 1.98

Efficiency

Gross Margin

0.00%

Sector 41.35%

Industry 41.35%

EBITDA Margin

-357.64%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-373.81%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

0.00%

Sector -35.47%

Industry -35.47%

Net Profit Margins

0.00%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.02

Sector 0.03

Industry 0.03

Profitability

ROE

Sector -57.36%

Industry -57.36%

ROA

Sector -59.44%

Industry -59.44%

ROIC

Sector -2,371.18%

Industry -2,371.18%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Net Debt / EBITDA

Sector -21.45

Industry -21.45

Net Debt / EBIT

Sector -8.32

Industry -8.32

Net Debt / Equity

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

0.89

Sector 0.46

Industry 0.46

Liabilities/Assets

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals VIE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VIE Viela Bio Inc.	$0.00	-	0.00%	0.00	0.00	0.00%	0.00%
PFE Pfizer Inc.	$28.06	18.78%	6.23%	36.34	1.84	5.07%	6.80%
ABBV AbbVie Inc.	$276.45	23.37%	2.47%	77.50	-82.49	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.39	-31.32%	4.83%	9.39	4.99	53.11%	35.32%
MRK Merck & Co. Inc.	$145.36	73.18%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$159.16	-4.81%	2.03%	19.02	4.90	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$59.57	41.54%	4.26%	12.97	5.39	41.59%	18.87%
ZTS Zoetis Inc.	$74.29	-47.23%	2.81%	11.76	9.85	83.77%	27.69%
AMGN Amgen Inc.	$413.08	44.07%	2.41%	25.51	19.08	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$749.56	32.05%	0.49%	17.80	2.43	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.87	71.58%	0.00%	31.72	91.40	288.13%	24.86%
MCK McKesson Corporation	$936.38	24.39%	0.36%	24.20	-28.76	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$509.93	21.08%	0.00%	29.37	6.39	21.76%	35.00%
CAH Cardinal Health Inc.	$237.32	52.35%	0.86%	32.46	-20.43	-62.92%	0.67%
ARGX argenx SE	$803.49	0.77%	0.00%	15.66	4.13	26.35%	25.62%
HRMY Harmony Biosciences Holdings Inc.	$40.30	51.73%	0.00%	12.88	2.34	18.14%	18.88%
BIIB Biogen Inc.	$226.46	47.00%	0.00%	40.08	1.77	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VIE - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Viela Bio

Viela Bio Inc.

Average Investor10 user rating

4.0 (0 people)

United States

9 years

Founded: 2017

2019

Time since IPO - 7 years

170

Employees

Viela Bio Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $375.83 million.

The company employs approximately 170 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Viela Bio Inc. reported $11.65 million in revenue, generating net income of $-150.67 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker VIE.

Market cap

Net worth

$375.83 million

$375,828,000.00

Assets

$423.26 million

$423,257,000.00

Total Shares Outstanding

54.89 million

54,891,000

Average Daily Trading Volume

$1.64 million

$1,641,740.72

Sector

Health Care

Industry

Biotechnology

VIE

VIE revenue and profits

Financial Results VIE

DRAG THE FRAME TO SEE MORE DATA

VIE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$936.38 23,12% (12M)

P/E

24.20

0.36%

ROE

-118.84%

P/BV

-28.76

CAH - Cardinal Health

$237.32 52,87% (12M)

P/E

32.46

0.86%

ROE

-62.92%

P/BV

-20.43

ABBV - AbbVie

$276.45 23,76% (12M)

P/E

77.50

2.47%

ROE

-106.44%

P/BV

-82.49

MRK - Merck & Co.

$145.36 74,00% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$159.16 --4,21% (12M)

P/E

19.02

2.03%

ROE

25.77%

P/BV

4.90

PFE - Pfizer

$28.06 21,21% (12M)

P/E

36.34

6.23%

ROE

5.07%

P/BV

1.84

BMY - Bristol-Myers Squibb

$59.57 41,94% (12M)

P/E

12.97

4.26%

ROE

41.59%

P/BV

5.39

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$936.38 23,12% (12 M)

P/L

24.20

0.36%

ROE

-118.84%

P/VP

-28.76

CAH - Cardinal Health

$237.32 52,87% (12 M)

P/L

32.46

0.86%

ROE

-62.92%

P/VP

-20.43

ABBV - AbbVie

$276.45 23,76% (12 M)

P/L

77.50

2.47%

ROE

-106.44%

P/VP

-82.49

MRK - Merck & Co.

$145.36 74,00% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$159.16 --4,21% (12 M)

P/L

19.02

2.03%

ROE

25.77%

P/VP

4.90

PFE - Pfizer

$28.06 21,21% (12 M)

P/L

36.34

6.23%

ROE

5.07%

P/VP

1.84

BMY - Bristol-Myers Squibb

$59.57 41,94% (12 M)

P/L

12.97

4.26%

ROE

41.59%

P/VP

5.39

Frequently Asked Questions

What is the price of Viela Bio (VIE) today?

The current price of Viela Bio (VIE) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Viela Bio (VIE) pay dividends?

Viela Bio (VIE) did not pay dividends over the past year.

Is Viela Bio (VIE) a good investment?

Viela Bio (VIE) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Viela Bio (VIE) stock?

You can buy Viela Bio (VIE) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol VIE and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Viela Bio (VIE) yield today?

Over the past month, Viela Bio (VIE) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -%.

If you were to purchase 100 shares of Viela Bio (VIE) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VIE

Viela Bio Inc.

Asset unavailable for trading

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VIE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING VIE WITH OTHER STOCK

ABOUT Viela Bio

Viela Bio Inc.

United States

9 years

2019

170

Financial Results VIE

VIE cash flow

Asset, Revenue and Profit Growth - VIE

VIE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions